Please Wait
Applying Filters...
menu
    • menu
    Top first-in-class drug candidates of 2025: Ionis’ donidalorsen, Sanofi’s fitusiran, Cytokinetics’ aficamten await FDA approval

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

    Stock Recap
    #PipelineProspector

    Menu

    Estramustine Phosphate Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    24/02/2025 Pfizer Inc
    U.S.A
    		 Pharmacia & Upjohn Company Kalamazoo US R0-CEP 2000-408 - Rev 00 Estramustine Phosphate Sodium 2001-11-16 Withdrawn by Holder TSE 2006-11-16
    24/02/2025 Pfizer Inc
    U.S.A
    		 Pharmacia & Upjohn Company Kalamazoo US R0-CEP 2000-409 - Rev 00 Estramustine Phosphate 2001-11-16 Withdrawn by Holder TSE 2006-11-17